General Information Treatment Overview

General Information

Treatment Overview

CyberKnife® Robotic Radiosurgery is a non-invasive1 treatment for cancerous and non-cancerous tumors and conditions where radiation therapy is indicated.

The CyberKnife System is routinely used to treat conditions in the brain, including, but not limited to, benign and malignant primary tumors, brain metastases, trigeminal neuralgia, acoustic neuromas and arteriovenous malformations (AVMs). CyberKnife radiosurgery is even used to treat complicated neurosurgical cases, while sparing important functions, such as hearing and vision.

Introduction to the CyberKnife M6 System

Clinical publications related to CyberKnife treatment cases Despite its name, CyberKnife treatment is not a surgical procedure. In fact, there is no cutting involved. The CyberKnife System is a non-invasive alternative for delivering radiation with the high level of precision required for stereotactic radiosurgery (SRS). Neurosurgeons and radiation oncologists turn to the CyberKnife System when more invasive techniques are deemed ineffective or too risky. CyberKnife treatments are suited for patients who cannot undergo surgical procedures as a result of:

  • Location or size of the tumor
  • Patient's health
  • Previous surgery or radiotherapy
  • Desire to avoid surgery

The CyberKnife System was cleared by the U.S. Food and Drug Administration in 1999 to treat diseases in the head and base of the skull. Since then, more than 100,000 patients have been successfully treated with the CyberKnife System for conditions within the brain.

1 Radiation therapy is completely non-invasive. In some cases, tiny gold markers (fiducials) that help distinguish the tumor from non-cancerous soft tissue are implanted with a minimally invasive procedure.